Stock DNA
Specialty Chemicals
JPY 287,694 Million (Small Cap)
7.00
NA
0.01%
0.36
5.68%
0.61
Revenue and Profits:
Net Sales:
198,682 Million
(Quarterly Results - Jun 2025)
Net Profit:
4,596 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.83%
0%
-0.83%
6 Months
11.35%
0%
11.35%
1 Year
18.72%
0%
18.72%
2 Years
19.61%
0%
19.61%
3 Years
27.4%
0%
27.4%
4 Years
11.84%
0%
11.84%
5 Years
24.81%
0%
24.81%
Kaneka Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.06%
EBIT Growth (5y)
8.45%
EBIT to Interest (avg)
20.06
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.22
Tax Ratio
27.10%
Dividend Payout Ratio
32.43%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
6.80%
ROE (avg)
6.41%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
0.55
EV to EBIT
10.74
EV to EBITDA
5.07
EV to Capital Employed
0.66
EV to Sales
0.52
PEG Ratio
0.16
Dividend Yield
0.01%
ROCE (Latest)
6.17%
ROE (Latest)
7.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2013
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
198,682.00
204,152.00
-2.68%
Operating Profit (PBDIT) excl Other Income
19,895.00
22,489.00
-11.53%
Interest
1,013.00
1,017.00
-0.39%
Exceptional Items
-261.00
-2,462.00
89.40%
Consolidate Net Profit
4,596.00
7,880.00
-41.68%
Operating Profit Margin (Excl OI)
41.10%
53.50%
-1.24%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.68% vs -1.42% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -41.68% vs -1.66% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
807,200.00
762,302.00
5.89%
Operating Profit (PBDIT) excl Other Income
83,697.00
72,863.00
14.87%
Interest
4,026.00
3,361.00
19.79%
Exceptional Items
-3,076.00
0.00
Consolidate Net Profit
26,805.00
24,775.00
8.19%
Operating Profit Margin (Excl OI)
48.40%
41.20%
0.72%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 5.89% vs 0.86% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 8.19% vs 2.91% in Mar 2024
About Kaneka Corp. 
Kaneka Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






